Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Grant/Award of 1,345,500 HEPA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/Award | 1,345,500 | n/a |
| Aug 13, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 2,000,000 | $100.0K |
| Apr 27, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 1,250,000 | $50.0K |
| Nov 6, 2025 | Tharimmune, Inc. (THAR) | Grant/Award | 20,000 | n/a |
| Aug 6, 2025 | Tharimmune, Inc. (THAR) | Grant/Award | 90,000 | n/a |
| Jun 23, 2025 | Tharimmune, Inc. (THAR) | Purchase | 60,806 | $90.0K |
| Jan 14, 2025 | Tharimmune, Inc. (THAR) | Grant/Award | 52,875 | n/a |
| Nov 13, 2024 | Tharimmune, Inc. (THAR) | Purchase | 5,000 | $10.1K |
| Oct 8, 2024 | Tharimmune, Inc. (THAR) | Purchase | 5,000 | $9.7K |
| Aug 12, 2024 | Tharimmune, Inc. (THAR) | Grant/Award | 38,087 | n/a |